MRI Findings Shed Light on Multiple Sclerosis
New MRI research shows that changes in brain blood flow associated with vein abnormalities are not specific for multiple sclerosis…
7T MRI: New Vision of Microvascular Abnormalities in Multiple Sclerosis
Yulin Ge, Vahe M. Zohrabian, and Robert I. Grossman Author information ► Copyright and License information ► The publisher’s final edited version of this article…
Stuart Schlossman
Researcher in Regina to discuss new advances in MRI techniques
REGINA — Dr. Melanie Martin hopes her research on the brain will allow her to make tools doctors can use…
Stuart Schlossman
fMRI Detects Brain Changes in MS Patients Following Cognitive Rehabilitation
Before reading the message found below, on February 29th, on StuMSRadio Blog Talk, please listen to our show to hear…
Stuart Schlossman
Brain Imaging in Multiple Sclerosis
Magnetic resonance imaging (MRI) of the brain is useful in the diagnosis and treatment ofmultiple sclerosis (MS), an inflammatory, demyelinating condition…
Stuart Schlossman
Gray Matter Atrophy May Serve as an Effective Outcome Measure for MS Clinical Trials
Studies show that gray matter atrophy correlates with disability progression and drives whole brain atrophy in MS. AMSTERDAM—Gray matter atrophy…
Stuart Schlossman
MRI Abnormalities in Multiple Sclerosis (MS) Vary With Distance From Lesions
Friday, December 16, 2011 Magnetic resonance imaging abnormalities in normal-appearing white matter in multiple sclerosis brains vary with the distance…
Stuart Schlossman
7T MRI Imaging, opens new windows into MS lesions
7.0-T MR image of postmortem tissue sample used for histologic comparison.Source: Radiology Combined analysis of 7T R2* and phase data…
Stuart Schlossman
MRI Tool Helps to Predict Conversion to Pediatric MS
AMSTERDAM – An MRI scoring tool helped to identify children with acute central nervous system demyelination who later developed pediatric…
Stuart Schlossman
MRI Predicts Response After Starting MS Treatment
AMSTERDAM – MRI of the brain performed 1 year after starting disease-modifying treatment for relapsing-remitting multiple sclerosis predicted response to…
Stuart Schlossman
